ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Overview Fund Activity
Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

59 hedge funds and large institutions have $24.3M invested in Zynerba Pharmaceuticals, Inc in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 20 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
-2
Holders Change %
-3.28%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
8
Reduced
20
Closed
20
Calls
$1.27M
Puts
$4.53M
Net Calls
-$3.27M
Net Calls Change
-$2.21M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$2.19M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$1.17M
3
BCM
3
BlueCrest Capital Management
Jersey
$795K
4
MWNA
4
Marshall Wace North America
New York
$744K
5
ECM
5
Element Capital Management
New York
$499K

Top Sellers

1
BlackRock
1
BlackRock
New York
$2.32M
2
State Street
2
State Street
Massachusetts
$176K
3
Northern Trust
3
Northern Trust
Illinois
$612K
4
ARTA
4
A.R.T. Advisors
New York
$165K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.12M
Name Holding Trade Value Shares
Change 		Shares
Change %
GT
76
Glenmede Trust
Pennsylvania
– -$3K -250 Closed
SWP
77
Stratos Wealth Partners
Ohio
– -$2K -189 Closed
KF
78
Krilogy Financial
Missouri
– -$1K -100 Closed
1 2 3
4